News & Perspective

Apr 07, 2016

Apr 07, 2016

News Scan for Apr 07, 2016

Third Ebola case in Liberia
Fatal Saudi MERS case
Flu vaccine gap in Denmark
Africa polio surveillance

Jul 10, 2012

Jul 10, 2012

Studies examine safety of adjuvanted pandemic vaccine

(CIDRAP News) – As researchers continue to sort out safety issues surrounding the monovalent vaccine used during the 2009 H1N1 flu pandemic, two new reports focusing mainly on an adjuvanted version suggest that immunization was safe for babies born to vaccinated pregnant women and that it was linked to a small but significant risk of Guillain-Barre syndrome (GBS) in some patients.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

May 06, 2004

May 06, 2004

CDC neutral on thimerosal in flu vaccine for toddlers

(CIDRAP News) – Almost 5 years ago, the American Academy of Pediatrics (AAP) and the US Public Health Service joined in calling for removal of the mercury-containing preservative thimerosal from vaccines. By 2001, all the vaccines recommended for children under age 7 were available without thimerosal or with only trace amounts.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»